Navigation Links
Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals
Date:11/25/2008

NUTLEY, N.J. and MONTVALE, N.J., Nov. 25 /PRNewswire-FirstCall/ -- Roche and Memory Pharmaceuticals (Nasdaq: MEMY) today announced that the two companies have signed a definitive merger agreement for Roche to acquire all the outstanding shares of Memory Pharmaceuticals in an all-cash transaction for an aggregate price of approximately USD 50 million.

Memory Pharmaceuticals develops innovative drug candidates for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. Memory Pharmaceuticals' nicotinic alpha-7 agonist drug candidates in these disease areas are already in partnered programmes with Roche: R3487/MEM 3454 is in phase II clinical trials for Alzheimer's disease and schizophrenia; R4996/MEM 63908 is in phase I for Alzheimer's disease.

"Acquiring Memory Pharmaceuticals will enable Roche to secure the future development of its promising nicotinic alpha-7 agonists," said William Burns, CEO Division Roche Pharmaceuticals. "The innovative work carried out by the scientists at Memory Pharmaceuticals will be fully integrated into Roche's R&D portfolio with the aim of providing new hope for patients and caregivers affected by devastating diseases such as Alzheimer's."

Jonathan Fleming, Chairman of the Board of Directors of Memory Pharmaceuticals said: "Since founding Memory Pharmaceuticals in 1998, we have focused on developing medicines that could make a real difference to the lives of CNS patients. I am proud of the progress our dedicated team has made and I am confident that Roche's capabilities and experience in the CNS field will enable our research to realise its full potential."

Terms of the agreement

Under the terms of the merger agreement, Roche will commence a tender offer to acquire all of the
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Roche Holds Sixth Annual Childrens Walk in Nutley
2. New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness
3. Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales
4. Primary Insomnia Tied to Brain Neurochemical Imbalance
5. Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults
6. Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
7. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
8. Genentech/Roche/Chugais Avastin Will Garner More Than 20 Percent of the Total Breast Cancer Drug Market in 2017
9. Balloon Manor Reappears in Rochester
10. Safety Threat to Rochester Still Remains Despite Approval Of Canadian Pacifics Railroad Acquisition Of DM&E
11. Rochester Medical Implants Achieves ISO 13485:2003 Certification for Medical Device Manufacturing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ical legislation would strengthen Medicare, improv... 8 SUMMARY: Yesterday... critical health care reform legislation that woul...nation by insurance companies that prices millions... ,, The Affordable Health Care for America Act ...
(Date:11/8/2009)... Praises House Passage of Health Care Reform Bill ...care, improve coverage for all Americans ,, HA... ,, SUMMARY: Last night the United States Ho... reform legislation that would strengthen Medicare...ompanies that prices millions of Americans out of ...
(Date:11/8/2009)... UCW Academy of Health holds open ho...Victoria, BC (Vocus) November 8, 2009 -- UCW Acade...eer in British Columbia’s health care indust...sday, November 25, 2009. , ,UCW Academy of Health...ation, nursing and social services, designs its pr...
(Date:11/8/2009)...r Costs and Crushing Taxes Nail Nation,s Job Creat...e/ -- In response to U.S. House passage of the hea...trepreneurship Council (SBE Council) president &am...nt: ,, "Make no mistake, those voting for H.R....th higher costs and crushing taxes and penalties. ...
(Date:11/8/2009)...NGTON, Nov. 7 Tonight t...Health Care for America Act, landmark health refor...access to quality, affordable, stable and secure h... down on some of the insurance industry,s worst pr...cans and cut the deficit by $104 billion over ten ...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:AARP Pennsylvania Key Vote News Alert 2Health News:AARP Pennsylvania Key Vote News Alert 3Health News:AARP Pennsylvania Key Vote News Alert 4Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3
...ts for the long-term efficacy of a meningitis C va...ve when given to infants older than 5 months.// ...n the United Kingdom in 1999. While the short-term...e vaccine was introduced to assess the long-term e...
...tients can avoid the risk of stroke by eating broi... those who ate fish; one to four// times a week ha...tbeat(known as atrial fibrillation), than those wh...ish cooked had to be broiled or baked rather than ...
...sease to travel by air? For the study researchers ...es involving air travel for heart patients -- such... on implantable automatic defibrillators and pacem...ir travelers sit for too long. Based on their f...
...sion in elderly people living in the community and...s found that // depression and its symptoms have b...le . The study, involved 250 participants in a ...nning, 29 percent of the people had depression. Am...
... a way to diagnose melancholic depression using an.../ levels of certain substances in the brain. Melan...arked by insomnia, loss of appetite, and loss of p...e brain appear to be linked to melancholic depress...
...that affect the lungs, including emphysema and chr...t // lung damage and irreversible airflow limitati...come inflamed, causing airflow obstruction and dif...ith medication. Asthmatics may have reason to w...
Other Medicine News:
(Date:11/6/2009)... Nov. 6 SCOLR Pharma, In...for the three and nine months ended September 30, ...esident and CEO, said, "We continue to advance dis...n formulation. Several potential partners have com...d external resources as they evaluate the potentia...
(Date:11/6/2009)...WASHINGTON, Pa., Nov. 6 In consult...FDA), McNeil Consumer Healthcare, Division of McNE...a limited number of product lots of TYLENOL® ...distinctive red EZ-OPEN CAP. McNeil is initiating ...mell or taste associated with these lots that led ...
(Date:11/6/2009)...., Nov. 6 Watson Pharmac...pharmaceutical company, announced today that Paul ...icer, will provide an overview and update of the C... Healthcare Conference on Wednesday, November 11, ... presentation will be webcast live and can be acce...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2People with type 2 diabetes not meeting important nutritional recommendations 56148 1People with type 2 diabetes not meeting important nutritional recommendations 56148 2People with type 2 diabetes not meeting important nutritional recommendations 56148 3Weeds that reinvented weediness 9780 1Study 3A Popular supplement quercetin does not enhance athletic performance 9778 1Study 3A Popular supplement quercetin does not enhance athletic performance 9778 2Study 3A Popular supplement quercetin does not enhance athletic performance 9778 3
...G 52364, Coley,s First Orally-Available, Small Mol...nical Development --, WELLESLEY, Mass., Oct. 29 ... today announced that it has,dosed its first subje...vailable TLR Therapeutic(TM) drug candidate for th...E. The candidate, CPG 52364, is a small,molecule T...
... Treatment Significantly Effective at Eight Weeks,...udy of,its kind on mood stabilizers, scientists fr...nd two other centers demonstrated that divalproex,...y improving symptoms of,bipolar I disorder in chil...ed today at the annual meeting of the American Aca...
Other Medicine Technology:Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus 2Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus 3Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus 4Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus 5Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder 2Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder 3Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder 4
...s new kit uses proteins produced with recombinant ...Latin America, and which are capable of detecting ...area. They are proteins with amino acid sequences ...) antigen. During the acute phase of the infection...
T. cruzi IgG CELISA
Chagas Quick Step
SPL™ Leads
Medicine Products: